Skip to content

20-332 - GOG-3039 - A Phase II Study of Abemaciclib in Combination with Letrozole in Advanced, Recurrent or Metastatic Endometrioid Endometrial Cancer

Status: open

Abemaciclib and Letrozole to Treat Endometrial Cancer

Patients with Endometrial Carcinoma

Contact Us Or call (251) 445-9834


This is a phase II single arm trial to evaluate the objective response rate of abemaciclib and letrozole in advanced stage, persistent or recurrent endometrioid endometrial cancer. Treatment will continue until either unacceptable toxicity, progression of disease, or investigator/patient request for withdrawal.


This trial is sponsored by National Cancer Institute (NCI).

Providers Associated With This Trial

    Sub Investigators

    This link will open in a new tab or window.